Exelixis

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$33.75-$49.62
Market Cap
$11.8B
Shares Short
27M

Financials

See more
Revenue (12 Mos)
$2.3B
Revenue Growth (YoY)
5.6%
Gross Profit (12 Mos)
$2.2B
Diluted EPS
$2.78

News

See more

Yahoo Finance • 7 days ago

Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus

Yahoo Finance • 11 days ago

Advanced Renal Cell Carcinoma Treatment Market to Grow by $3.1 Billion During 2026-2030: Global Industry Assessment Featuring Pfizer, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Novartis and More

Yahoo Finance • 11 days ago

Renal Cell Carcinoma Market Report 2026-2030 & 2035: Increasing Immunotherapy and Precision Oncology Programs Drives Market Expansion, Reaching USD 6.09 Billion by 2030

Yahoo Finance • 12 days ago

Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry

About

CEO
Dr. Michael M. Morrissey Ph.D.
CFO
Mr. Christopher J. Senner
Address
1851 Harbor Bay Parkway, Alameda, CA, United States, 94502
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
1,077